Compare SMTI & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
| Metric | SMTI | NEN |
|---|---|---|
| Founded | 1982 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.2M | 209.2M |
| IPO Year | 2008 | 1995 |
| Metric | SMTI | NEN |
|---|---|---|
| Price | $22.02 | $58.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 39.4K | 766.0 |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | $15,586,976.00 | ★ $89,196,544.00 |
| Revenue This Year | $17.31 | N/A |
| Revenue Next Year | $12.48 | N/A |
| P/E Ratio | $426.80 | ★ $19.68 |
| Revenue Growth | ★ 32.47 | 10.76 |
| 52 Week Low | $16.05 | $56.00 |
| 52 Week High | $35.70 | $74.49 |
| Indicator | SMTI | NEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 44.85 |
| Support Level | $20.52 | $56.50 |
| Resistance Level | $24.17 | $60.90 |
| Average True Range (ATR) | 1.42 | 0.86 |
| MACD | -0.18 | -0.06 |
| Stochastic Oscillator | 43.65 | 38.46 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.